跳至主要内容
临床试验/ISRCTN59927814
ISRCTN59927814已完成不适用

Vitamin D supplementation in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients: a randomised, placebo-controlled, parallel, double-blind study

niversity of Dundee0 个研究点目标入组 50 人开始时间: 2010年3月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients diagnosed with ME/CFS (fulfils the Fukuda [1994] and Canadian [2003] criteria)
  • 2. Serum 25(OH)D levels < 75 nmol/l
  • 3. Male or female, aged 18 - 65

排除标准

  • 1. Patients not diagnosed with ME/CFS
  • 2. Patients already taking Vitamin D supplements (fish oils will be permitted)
  • 3. Estimated Glomerular Filtration Rate (GFR) < 40 ml/min (by MDRD4 method)
  • 4. Adjusted serum calcium < 2.15 or > 2.60 mmol/L
  • 5. Liver Function Test (LFT) > 3x upper limit of normal (ULN)
  • 6. Known metastatic malignancy
  • 7. History of kidney stones
  • 8. History of sarcoidosis or osteoporosis
  • 9. Lying systolic blood pressure (BP) < 80 mm Hg
  • 10. Pregnant, lactating or of childbearing age and not taking reliable contraception
  • 11. Patients diagnosed with psychiatric disorder (including depression) within the past 5 years
  • 12. Patients diagnosed with schizophrenia, mania, substance abuse/dependence, or an eating disorder at any time
  • 13. Patients with other known organic cause for their symptoms
  • 14. Unable to give written informed consent

研究者

发起方
niversity of Dundee

相似试验